All Stories

  1. Characterising the consumer smartphone app landscape for skin cancer prevention and early detection: a cross‑sectional study report
  2. Key factors influencing patient experience of total body photography (TBP) in skin cancer screening and diagnosis: a modified Delphi study
  3. Experiences of patient-led melanoma surveillance and teledermatology in underserved groups in the Melanoma Self-Surveillance Trial: A qualitative sub-study
  4. Constructs Influencing Patient Perceptions of Use of AI in Medical Imaging Analysis: Systematic Review
  5. Quality of life and patient-reported outcomes after non-surgical management of early-stage endometrial cancer and endometrial hyperplasia with atypia: a long-term follow-up of the feMMe Phase II randomized clinical trial
  6. Charting a new melanoma risk factor: Satellite Naevus Prevalence in High-Risk and Population-Based Cohorts
  7. Nevus clustering on the back associated with in situ melanoma in a Queensland melanoma high-risk cohort
  8. Evolving landscape of consumer‐based smartphone apps for skin cancer prevention and early detection
  9. Motivation-informed digital reminders were no more effective than standard reminders for trial task completion in a randomised Study Within A Trial (SWAT)
  10. Women’s lived experiences of being diagnosed with early-stage endometrial cancer and making treatment decisions: A systematic review and thematic synthesis
  11. Long-term oncological and reproductive outcomes following treatment with the levonorgestrel intrauterine device for endometrial hyperplasia and adenocarcinoma – Results from the feMMe phase 2 randomized clinical trial
  12. Psychological Wellbeing After a Diagnosis of Melanoma In Situ: A Qualitative Interview Study
  13. Constructs Influencing Patient Perceptions of Use of AI in Medical Imaging Analysis: Systematic Review (Preprint)
  14. Use of digital health interventions by outdoor workplaces in Australia: A focus on skin cancer prevention interventions
  15. Skin cancer awareness and sun protection advice for outdoor workers in Australia: Review of communication channels to optimise reach and relevance
  16. Automated classification of site-specific cutaneous photodamage using a convolutional neural network and 3D total body photography
  17. Exploring Melanoma Awareness in the Australian Adult Population: A Cross‐Sectional Survey
  18. 3D-total body photography identifies cutaneous phenotypes associated with late-onset invasive melanoma risk
  19. The Impact of Multidisciplinary Research on Progress in Skin Cancer Prevention
  20. Automating skin colour assessment using 3D total‐body photography: A proof‐of‐concept study
  21. An Overview of Data Analysis Approaches and Biases in Unveiling the Impact of COVID-19 on Melanoma Diagnosis
  22. A longitudinal dataset of tile and corresponding dermoscopic images with metadata for identifying skin cancers
  23. Practice Guidelines for Teledermatology in Australia: 2025 Update
  24. Three-Dimensional Total Body Photography Enables Automated Obesity-Related Comorbidity Screening in Dermatology
  25. Understanding Contemporary Endometrial Cancer Survivorship Issues: Umbrella Review and Healthcare Professional Survey
  26. Privacy in Imaging for Dermatology Research
  27. What Are Patients’ Perceptions and Attitudes Regarding the Use of Artificial Intelligence in Skin Cancer Screening and Diagnosis? Narrative Review
  28. Informing a Position Statement on the Use of Large Language Models and AI Scribes in Dermatology in Australia
  29. Unpredictable interdependence of invasive and in situ melanoma
  30. Attitudes Towards the Use of Artificial Intelligence in Dermatology: A Survey of Australian Dermatologists
  31. The deep imaging phenotype for melanoma risk stratification
  32. Estimation of Body Mass Index from 3-Dimensional Total Body Photography
  33. Exploring the Views of Dermatologists, General Practitioners, and Melanographers on the Use of AI Tools in the Context of Good Decision-Making When Detecting Melanoma: Qualitative Interview Study
  34. Combining Automated Lesion Risk and Change Assessment Improves Melanoma Detection: A Retrospective Accuracy Study
  35. Skin 2.0: How Cutaneous Digital Twins Could Reshape Dermatology
  36. The impact of surgical complications on obstetricians’ and gynecologists’ well-being and coping mechanisms as second victims
  37. Sun safe practice in the sport sector: industry forum report September 2025
  38. Incidence and patterns of newly developed pigmented lesions in adults at high risk for melanoma
  39. Automated Detection of Pigmented Iris Freckles Using a Deep Neural Network for Cutaneous Melanoma Risk
  40. Participant Motivators and Expectations in the MEL-SELF Randomized Clinical Trial of Patient-Led Surveillance for Recurrent Melanoma: Content Analysis of Survey Responses
  41. Implementation of Patient-Reported Outcomes in a Medical Oncology Setting (the iPROMOS Study): Type II Hybrid Implementation Study
  42. Targeted Screening for Cancer: Learnings and Applicability to Melanoma: A Scoping Review
  43. Comparison of artificial intelligence smartphone applications for skin cancer risk stratification of pigmented lesions: An observational study
  44. Protocol for the process evaluation of the GOAL trial: investigating how comprehensive geriatric assessment (CGA) improves patient-centred goal attainment in older adults with chronic kidney disease in the outpatient setting
  45. Exploring the Views of Dermatologists, General Practitioners, and Melanographers on the Use of AI Tools in the Context of Good Decision-Making When Detecting Melanoma: Qualitative Interview Study (Preprint)
  46. A Narrative Review: Opportunities and Challenges in Artificial Intelligence Skin Image Analyses Using Total Body Photography
  47. Participant Motivators and Expectations in the MEL-SELF Randomized Clinical Trial of Patient-Led Surveillance for Recurrent Melanoma: Content Analysis of Survey Responses (Preprint)
  48. Working together to improve type 2 diabetes care: a Participatory Design project to address identified needs of people with diabetes and their healthcare professionals
  49. Balancing the risks and benefits of sun exposure: A revised position statement for Australian adults
  50. Re: Incidence of in situ vs invasive melanoma: testing the “obligate precursor” hypothesis
  51. Learnings from implementing a surgical training program
  52. Pre-post feasibility trial of a telephone-delivered exercise intervention for patients during chemotherapy for recurrent ovarian cancer: the ECHO-R trial protocol
  53. Implementation of Patient-Reported Outcomes in a Medical Oncology Setting (the iPROMOS Study): Type II Hybrid Implementation Study (Preprint)
  54. Melanoma screening workshop summary report
  55. Skin cancer awareness in the personal services industry
  56. Skin Cancer Prevention Queensland: Sunscreen Industry Forum Report
  57. Feasibility and safety of a surgical training program in total laparoscopic hysterectomy: Results of a pilot trial
  58. Position statement: balancing the harms and benefits of sun exposure
  59. Spatial Randomness in the Distribution of Acquired Melanocytic Nevi of the Back in a Population-Based Sample
  60. Study protocol for The GOAL Trial: comprehensive geriatric assessment for frail older people with chronic kidney disease to increase attainment of patient-identified goals—a cluster randomised controlled trial
  61. Exercise during CHemotherapy for Ovarian cancer (ECHO) trial: design and implementation of a randomised controlled trial
  62. Sun Exposure Summit position statement
  63. Consumer views of melanoma early detection using 3D total‐body photography: cross‐sectional survey
  64. Skin Cancer Prevention Queensland: towards a future of reduced skin cancer burden for Queenslanders
  65. Perspectives and Experiences of Patient-Led Melanoma Surveillance Using Digital Technologies From Clinicians Involved in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Study
  66. The dynamic nature of naevi in adulthood: prospective population-based study using three-dimensional total-body photography
  67. Informing a position statement on the use of artificial intelligence in dermatology in Australia
  68. Consumer perceptions on privacy and confidentiality in dermatology for 3D total‐body imaging
  69. Can people take high‐quality images using mobile dermatoscopes at home on easy‐to‐see and difficult‐to‐see body areas?
  70. Body Site Distribution of Acquired Melanocytic Naevi and Associated Characteristics in the General Population of Caucasian Adults: A Scoping Review
  71. Toward Incorporating Health-Related Quality of Life as Coprimary End Points in Clinical Trials: Time to Achieve Clinical Important Differences and QoL Profiles
  72. Experiences of Patient-Led Surveillance, Including Patient-Performed Teledermoscopy, in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Study
  73. Perspectives and experiences of patient-led melanoma surveillance using digital technologies from clinicians involved in the MEL-SELF pilot randomised controlled trial: Qualitative Interview Study (Preprint)
  74. A qualitative analysis of the needs and wishes of people with type 2 diabetes and healthcare professionals for optimal diabetes care
  75. Experience from an outright ban of commercial sunbeds in the Australian context
  76. Digital Technology in Skin Cancer Prevention and Early Detection
  77. Digital Technology in Skin Cancer Prevention and Early Detection (Preprint)
  78. Reasons behind Low Cervical Screening Uptake among South Asian Immigrant Women: A Qualitative Exploration
  79. Identification of Suspicious Naevi from Dermoscopy Images Using Machine Learning
  80. Experiences of Patient-Led Surveillance, Including Patient-Performed Teledermoscopy, in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Study (Preprint)
  81. Factors influencing participants’ engagement with an interactive text-message intervention to improve sun protection behaviors: “SunText” randomized controlled trial
  82. Consumer Preference and Willingness to Pay for Direct-to-Consumer Mobile Teledermoscopy Services in Australia
  83. The Additive Value of 3D Total Body Imaging for Sequential Monitoring of Skin Lesions: A Case Series
  84. Describing the Skin Surface Ecosystem Using 3D Total Body Photography
  85. Anatomic Distribution of Cherry Angiomas in the General Population
  86. Reproducible Naevus Counts Using 3D Total Body Photography and Convolutional Neural Networks
  87. The impact on health outcomes of implementing electronic health records to support the care of older people in residential aged care: A scoping review
  88. Review of educational tools for skin self‐examination: A qualitative analysis of laypeople’s preferences
  89. Weight and weight control behaviors during long‐term endometrial cancer survivorship: Results of the Laparoscopic Approach to Cancer of the Endometrium long‐term follow‐up study
  90. High variability in anatomic patterns of cutaneous photodamage: a population‐based study
  91. Development of a Checklist Tool to Assess the Quality of Skin Lesion Images Acquired by Consumers Using Sequential Mobile Teledermoscopy
  92. Clinical utility of skin cancer and melanoma risk scores for population screening: TRoPICS study
  93. The Importance of Incorporating Human Factors in the Design and Implementation of Artificial Intelligence for Skin Cancer Diagnosis in the Real World
  94. Changes in cancer preventive behaviours, screening and diagnosis during COVID‐19
  95. Review of smartphone mobile applications for skin cancer detection: what are the changes in availability, functionality, and costs to users over time?
  96. Quality of life following minimally invasive hysterectomy compared to abdominal hysterectomy: A metanalysis
  97. Incidence and risk factors for lower limb lymphedema associated with endometrial cancer: Results from a prospective, longitudinal cohort study.
  98. Fertility-sparing treatment in early endometrial cancer: current state and future strategies
  99. Virtual melanoma checks during a pandemic
  100. Practice guidelines for teledermatology in Australia
  101. Early detection of melanoma: a consensus report from the Australian Skin and Skin Cancer Research Centre Melanoma Screening Summit
  102. A review of literature supporting the development of practice guidelines for teledermatology in Australia
  103. The use of CAM products, practices, and practitioners by long-term endometrial cancer survivors in Australia
  104. Consumer skin cancer screening preferences
  105. Accuracy of mobile digital teledermoscopy for skin self-examinations in adults at high risk of skin cancer: an open-label, randomised controlled trial
  106. Long‐term deaths from melanoma according to tumor thickness at diagnosis
  107. Tweets about sunburn
  108. Prevention versus early detection for long-term control of melanoma and keratinocyte carcinomas: a cost-effectiveness modelling study
  109. Self‐reported naevus density may lead to misclassification of melanoma risk
  110. Using Mobile Health Technology and Social Media for the Prevention and Early Detection of Skin Cancer
  111. Is Teledermoscopy Ready to Replace Face-to-Face Examinations for the Early Detection of Skin Cancer? Consumer Views, Technology Acceptance, and Satisfaction with Care
  112. What Can Twitter Tell Us about Skin Cancer Communication and Prevention on Social Media?
  113. Factors in Randomized Controlled Trials Reported to Impact the Implementation of Patient-Reported Outcome Measures Into Routine Care: Protocol for a Systematic Review
  114. Unintended sunburn after applying sunscreen
  115. 3D Total Body Photography for early melanoma detection
  116. What is needed by staff to implement PROMs into routine oncology care? A qualitative study with the multi‐disciplinary team
  117. Multidisciplinary cancer care in Australia
  118. UV detection stickers can assist people to reapply sunscreen
  119. Is there a role for digital technology in measuring the value of skin self‐examination?
  120. Factors in Randomized Controlled Trials Reported to Impact the Implementation of Patient-Reported Outcome Measures Into Routine Care: Protocol for a Systematic Review (Preprint)
  121. How to train practising gynaecologists in total laparoscopic hysterectomy: protocol for the stepped-wedge IMAGINE trial
  122. Patient-Reported Experiences After Hysterectomy: A Cross-Sectional Study of the Views of Over 2300 Women
  123. Patient Portals Facilitating Engagement With Inpatient Electronic Medical Records: A Systematic Review
  124. Can clinical decision making be enhanced by artificial intelligence?
  125. Challenges and controversies in the conservative management of uterine and ovarian cancer
  126. How many patients enter endometrial cancer surgery with psychotropic medication prescriptions, and how many receive a new prescription perioperatively?
  127. The iPROMOS protocol: a stepped-wedge study to implement routine patient-reported outcomes in a medical oncology outpatient setting
  128. Evaluating healthcare practitioners’ views on store-and-forward teledermoscopy services for the diagnosis of skin cancer
  129. Sun protection behavior after diagnosis of high-risk primary melanoma and risk of a subsequent primary
  130. A Mobile Technology Intervention With Ultraviolet Radiation Dosimeters and Smartphone Apps for Skin Cancer Prevention in Young Adults: Randomized Controlled Trial
  131. Patient Portals Facilitating Engagement With Inpatient Electronic Medical Records: A Systematic Review (Preprint)
  132. Consumer Acceptance and Expectations of a Mobile Health Application to Photograph Skin Lesions for Early Detection of Melanoma
  133. Redesigning Skin Cancer Early Detection and Care Using a New Mobile Health Application: Protocol of the SKIN Research Project, a Randomised Controlled Trial
  134. Factors associated with human papillomavirus (HPV) test acceptability in primary screening for cervical cancer: A mixed methods research synthesis
  135. Fighting Melanoma with Smartphones: A Snapshot of Where We are a Decade after App Stores Opened Their Doors
  136. Using Advances in Skin Imaging Technology and Genomics for the Early Detection and Prevention of Melanoma
  137. Why a randomized melanoma screening trial may be a good idea
  138. ‘Mind your Moles’ study: protocol of a prospective cohort study of melanocytic naevi
  139. Obesity in total laparoscopic hysterectomy for early stage endometrial cancer: health gain and inpatient resource use
  140. Are psychological interventions effective on anxiety in cancer patients? A systematic review and meta-analyses
  141. All-cause death in young women with endometrial cancer who receive progesterone therapy
  142. Capturing Ultraviolet Radiation Exposure and Physical Activity: Feasibility Study and Comparison Between Self-Reports, Mobile Apps, Dosimeters, and Accelerometers
  143. Pelvic floor functional outcomes after total abdominal vs total laparoscopic hysterectomy for endometrial cancer
  144. Chemotherapy in patients with unresected pancreatic cancer in Australia: A population-based study of uptake and survival
  145. A Mobile Technology Intervention With Ultraviolet Radiation Dosimeters and Smartphone Apps for Skin Cancer Prevention in Young Adults: Randomized Controlled Trial (Preprint)
  146. Clinical trials, culture and language: More than meets the eye?
  147. Effect of solar ultraviolet radiation exposure on serum 25(OH)D concentration: a pilot randomised controlled trial
  148. Capturing Ultraviolet Radiation Exposure and Physical Activity: Feasibility Study and Comparison Between Self-Reports, Mobile Apps, Dosimeters, and Accelerometers (Preprint)
  149. Psychological distress among Indigenous Australian cancer survivors
  150. Time and treatments: It is what you make of it that counts
  151. Do hand-addressed envelopes improve community response rates for a longitudinal study?
  152. Lymphedema following gynecological cancer: Results from a prospective, longitudinal cohort study on prevalence, incidence and risk factors
  153. The validity and reliability of remote diabetic foot ulcer assessment using mobile phone images
  154. Cost-Effectiveness Analysis of a Skin Awareness Intervention for Early Detection of Skin Cancer Targeting Men Older Than 50 Years
  155. Nutrition interventions in patients with gynecological cancers requiring surgery
  156. Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial Cancer
  157. Anxiety, depression and quality of life in people with pancreatic cancer and their carers
  158. Efficacy of smartphone applications in high-risk pigmented lesions
  159. The Living Well after Breast Cancer™ Pilot Trial: a weight loss intervention for women following treatment for breast cancer
  160. Greater Precision in Melanoma Prevention
  161. Factors associated with quality of care for patients with pancreatic cancer in Australia
  162. Living well after breast cancer randomized controlled trial protocol: evaluating a telephone-delivered weight loss intervention versus usual care in women following treatment for breast cancer
  163. A Randomized Trial on the Effect of Exercise Mode on Breast Cancer–Related Lymphedema
  164. Consumer teledermoscopy for melanoma diagnosis
  165. Can skin cancer prevention be improved through mobile technology interventions? A systematic review
  166. Determinants of survival and attempted resection in patients with non-metastatic pancreatic cancer: An Australian population-based study
  167. Variations in supportive care needs of patients after diagnosis of localised cutaneous melanoma: a 2-year follow-up study
  168. Real-world surgical outcomes of a gelatin-hemostatic matrix in women requiring a hysterectomy: a matched case-control study
  169. Economics of teledermatology
  170. Do breast cancer survivors benefit from prophylactic removal of uterus and ovaries? A population-based data linkage replication study
  171. Determinants of Outcomes Following Resection for Pancreatic Cancer—a Population-Based Study
  172. Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study
  173. Erratum to: QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30
  174. Self-Reported Changes in Sun-Protection Behaviors at Different Latitudes in Australia
  175. Compression use during an exercise intervention and associated changes in breast cancer-related lymphedema
  176. Health-related quality of life among Indigenous Australians diagnosed with cancer
  177. Estimating Skin Cancer Risk: Evaluating Mobile Computer-Adaptive Testing
  178. Using a Delphi process to determine optimal care for patients with pancreatic cancer
  179. QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30
  180. A systematic review and meta-analysis of prescribing practices of antidepressants in cancer patients
  181. Mediation of improvements in sun protective and skin self-examination behaviours: results from the healthy text study
  182. Beyond survivorship? A discursive analysis of how people with pancreatic cancer negotiate identity transitions in their health
  183. A tsunami of unmet needs: pancreatic and ampullary cancer patients' supportive care needs and use of community and allied health services
  184. Review of the Evidence of Lymphedema Treatment Effect
  185. Quality of life after early enteral feeding versus standard care for proven or suspected advanced epithelial ovarian cancer: Results from a randomised trial
  186. Consumer preferences for teledermoscopy screening to detect melanoma early
  187. Psychometric properties of an Australian supportive care needs assessment tool for Indigenous patients with cancer
  188. Redefining Dermatologists’ Role in Skin Cancer Early Detection and Follow-up Care
  189. Lower preoperative quality of life increases postoperative risk of adverse events in women with endometrial cancer: Results from the LACE trial
  190. Consumer Teledermoscopy
  191. Incidence, Risk Factors, and Estimates of a Woman’s Risk for Developing Secondary Lower Limb Lymphedema and Lymphedema-Specific Supportive Care Needs in Women Treated for Endometrial Cancer
  192. Association between single-nucleotide polymorphisms in growth factor genes and quality of life in men with prostate cancer and the general population
  193. User preferences for text message-delivered skin cancer prevention and early detection
  194. Can skin cancer prevention and early detection be improved via mobile phone text messaging? A randomised, attention control trial
  195. Women with self-reported lower-limb lymphedema after treatment for gynecological cancers: are they more likely to self-report psychosocial symptoms and less likely to use services?
  196. Systematic Review of Interventions to Improve the Provision of Information for Adults with Primary Brain Tumors and Their Caregivers
  197. Exercise barriers self-efficacy: development and validation of a subcale for individuals with cancer-related lymphedema
  198. Incidence, risk factors and estimates of a woman's risk of developing secondary lower limb lymphedema and lymphedema-specific supportive care needs in women treated for endometrial cancer
  199. Women’s Perceptions of Their Lifestyle and Quality of Life Several Years After a Diagnosis of Endometrial Cancer
  200. Evaluation of a skin self examination attitude scale using an item response theory model approach
  201. Prevalence, predictors, and correlates of supportive care needs among women 3–5 years after a diagnosis of endometrial cancer
  202. Changes in Outdoor Workersʼ Sun-Related Attitudes, Beliefs, and Behaviors
  203. Improving treatment for obese women with early stage cancer of the uterus: Rationale and design of the levonorgestrel intrauterine device±Metformin±weight loss in endometrial cancer (feMME) trial
  204. Primary Prevention of Skin Cancer
  205. Lesion Selection by Melanoma High-Risk Consumers During Skin Self-examination Using Mobile Teledermoscopy
  206. Quality of life of women with lower limb swelling or lymphedema 3–5years following endometrial cancer
  207. Clinical Skin Examination Outcomes After a Video-Based Behavioral Intervention
  208. Uptake of Skin Self-examination and Clinical Examination Behavior by Outdoor Workers
  209. Mobile Medical Applications for Melanoma Risk Assessment: False Assurance or Valuable Tool?
  210. Teledermatology: Its Use in the Detection and Management of Actinic Keratosis
  211. Interventions to decrease skin cancer risk in outdoor workers: update to a 2007 systematic review
  212. Serum HE4 as a prognostic marker in endometrial cancer — A population based study
  213. Skin cancer detection by one click — are we any closer?
  214. Epidural analgesia is associated with an increased incidence of postoperative complications in patients requiring an abdominal hysterectomy for early stage endometrial cancer
  215. The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer-A population-based data linkage study
  216. An Instrument to Measure Adherence to Weight Loss Programs: The Compliance Praxis Survey-Diet (COMPASS-Diet)
  217. Identification of doctors at risk of recurrent complaints: a national study of healthcare complaints in Australia
  218. Advances in Skin Cancer Early Detection and Diagnosis
  219. The HealthyTexts study: A randomized controlled trial to improve skin cancer prevention behaviors among young people
  220. Determinants of Uptake of Whole-Body Skin Self-Examination in Older Men
  221. Nomogram to Predict the Probability of Relapse in Patients Diagnosed With Borderline Ovarian Tumors
  222. Enhanced Skin Self-examination: A Novel Approach to Skin Cancer Monitoring and Follow-up
  223. The cost-effectiveness of total laparoscopic hysterectomy compared to total abdominal hysterectomy for the treatment of early stage endometrial cancer
  224. Differences in Epidural and Analgesic Use in Patients with Apparent Stage I Endometrial Cancer Treated by Open versus Laparoscopic Surgery: Results from the Randomised LACE Trial
  225. Predicting positive and negative impacts of cancer among long-term endometrial cancer survivors
  226. Health professionals' perspectives on information provision for patients with brain tumours and their families
  227. Risk factors to predict the incidence of surgical adverse events following open or laparoscopic surgery for apparent early stage endometrial cancer: Results from a randomised controlled trial
  228. Quality and Readability of Information Materials for People with Brain Tumours and Their Families
  229. How people construct their experience of living with secondary lymphoedema in the context of their everyday lives in Australia
  230. Characteristics of men aged 50 years or older who do not take up skin self-examination following an educational intervention
  231. Improved surgical safety after laparoscopic compared to open surgery for apparent early stage endometrial cancer: Results from a randomised controlled trial
  232. The Children and Sunscreen Study
  233. Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: A meta-analysis and systematic review of the literature
  234. Possible Genetic Predisposition to Lymphedema after Breast Cancer
  235. Development and piloting of a brain tumour-specific question prompt list
  236. Personalised electronic messages to improve sun protection in young adults
  237. The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer
  238. Safety, feasibility and effects of an individualised walking intervention for women undergoing chemotherapy for ovarian cancer: a pilot study
  239. Lymphedema After Breast or Gynecological Cancer: Use and Effectiveness of Mainstream and Complementary Therapies
  240. Impact of a Video-Based Intervention to Improve the Prevalence of Skin Self-examination in Men 50 Years or Older
  241. Quality of life of women with lower-limb lymphedema following gynecological cancer
  242. Body-site distribution of skin cancer, pre-malignant and common benign pigmented lesions excised in general practice
  243. Factors associated with recall of media reports about vitamin D and sun protection
  244. Prospective, non-randomized phase 2 clinical trial of carboplatin plus paclitaxel with sequential radical pelvic radiotherapy for uterine papillary serous carcinoma
  245. In Vitro Model of Vitamin D Synthesis by UV Radiation in an Australian Urban Environment
  246. Laparoscopy or laparotomy for early endometrial cancer? – Authors' reply
  247. Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomised trial
  248. Patterns, correlates, and prognostic significance of quality of life following breast cancer
  249. Repeat participation in colorectal cancer screening utilizing fecal occult blood testing: A community-based project in a rural setting
  250. Pretreatment malnutrition and quality of life - association with prolonged length of hospital stay among patients with gynecological cancer: a cohort study
  251. Knowledge about health benefits of vitamin D in Queensland Australia
  252. Seasonal Variation in Measured Solar Ultraviolet Radiation Exposure of Adults in Subtropical Australia
  253. The skin awareness study: Promoting thorough skin self-examination for skin cancer among men 50years or older
  254. Does quality of life among breast cancer survivors one year after diagnosis differ depending on urban and non-urban residence? A comparative study
  255. Gynecological cancer survivors and community support services: referral, awareness, utilization and satisfaction
  256. What determines the health‐related quality of life among regional and rural breast cancer survivors?
  257. Depression, anxiety and body image after treatment for invasive stage one epithelial ovarian cancer
  258. Recruiting older adults to health research studies: A systematic review
  259. Lymphedema Following Breast Cancer
  260. Vitamin D and sun protection: The impact of mixed public health messages in Australia
  261. Views of supervisors of colonoscopy training on quality issues for the national bowel cancer screening program in Australia
  262. Factors Associated With the Number of Lesions Excised for Each Skin Cancer
  263. The Queensland cancer risk study: general population norms for the Functional Assessment of Cancer Therapy–General (FACT‐G)
  264. Disease-free survival after vaginal vault brachytherapy versus observation for patients with node-negative intermediate-risk endometrial adenocarcinoma
  265. Treatment for upper-limb and lower-limb lymphedema by professionals specializing in lymphedema care
  266. Lymphedema After Breast Cancer: Incidence, Risk Factors, and Effect on Upper Body Function
  267. Unmet supportive care needs and interest in services among patients with a brain tumour and their carers
  268. Gynecological cancer survivors’ health behaviors and their associations with quality of life
  269. Health-related quality of life 18 months after breast cancer: comparison with the general population of Queensland, Australia
  270. Elderly patients with stage III or IV ovarian cancer: should they receive standard care?
  271. Quality of life among patients with a brain tumor and their carers
  272. Medical cost-offsets from psychosocial care in breast cancer
  273. Sun protection and low levels of vitamin D: are people concerned?
  274. The effect of an educational programme to improve the skills of general practitioners in diagnosing melanocytic/pigmented lesions
  275. Lymphedema after gynecological cancer treatment
  276. Diagnosis and management costs of suspicious skin lesions from a population-based melanoma screening programme
  277. Malnutrition among gynaecological cancer patients
  278. Reply
  279. What motivates men age ≥ 50 years to participate in a screening program for melanoma?
  280. Total laparoscopic versus open surgery for stage 1 endometrial cancer: The LACE randomized controlled trial
  281. Supportive care needs of people with brain tumours and their carers
  282. Do Centralised Skin Screening Clinics Increase Participation in Melanoma Screening (Australia)?
  283. Clinical outcomes from skin screening clinics within a community-based melanoma screening program
  284. Who attends skin cancer clinics within a randomized melanoma screening program?
  285. Voluntary whole-blood donors, and compensated platelet donors and plasma donors: Motivation to donate, altruism and aggression
  286. Increase in skin cancer screening during a community-based randomized intervention trial
  287. The functional assessment of cancer-vulvar: Reliability and validity
  288. Acceptability and feasibility of a community-based screening programme for melanoma in Australia
  289. Comparability of Skin Screening Histories Obtained by Telephone Interviews and Mailed Questionnaires: A Randomized Crossover Study
  290. The view from two sides: a qualitative study of community and medical perspectives on screening for colorectal cancer using FOBT
  291. Primary prevention of skin cancer: a review of sun protection in Australia and internationally
  292. Vulvar cancer patients' quality of life: a qualitative assessment
  293. Attitudes and intentions in relation to skin checks for early signs of skin cancer
  294. Prevalence of Whole-Body Skin Self-Examination in a Population at High Risk for Skin Cancer (Australia)
  295. Validity of Self-reported Skin Screening Histories
  296. Impaired Quality of Life in Patients Commencing Radiotherapy for Cancer
  297. Anemia before and during concurrent chemoradiotherapy in patients with cervical carcinoma: Effect on progression-free survival
  298. Acute Side Effects during 3-D-Planned Conformal Radiotherapy of Prostate Cancer
  299. Impact of Videotaped Information on Frequency and Confidence of Breast Self-Examination
  300. Measurement of Quality of Life in Head and Neck Cancer Patients Utilizing the Quality of Life Radiation Therapy Questionnaire
  301. Primary fallopian tube carcinoma: the Queensland experience
  302. Impact of hemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinoma
  303. Quality of life changes during conformal radiation therapy for prostate carcinoma